美團(03690.HK)績後遭非執董沈南鵬減持套現60億元 股價跌逾3%
美團(03690.HK)於3月25日發布全年業績,禁售期結束不足一周即遭非執董、紅杉資本創始管理合夥人沈南鵬減持。根據聯交所股權披露系統資料顯示,沈南鵬於於3月31日透過場外交易減持美團約2,557.85萬股,每股成交價為153.8元,套現逾39.3億元。
於本周三(6日),沈南鵬再透過場內交易每股平均價161.7422元,及場外交易每股平均158.65元,減持美團約1,296.4萬股,估計套現近21億元。兩次減持共套現逾60億元。
減持後,沈南鵬於美團持股量由4.68%下降至3.98%。
該股今早最低見153.4元,現報154.1元,跌3.3%,成交578萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.